Sunday, August 3, 2008

bomb hits military convoy near Kabul

This must end Asap!!!!
The mission is dead

------------------------------------------------------------

CBC News
One dead as roadside bomb hits military convoy near Kabul
Another person wounded; victims thought to be American
Last Updated: Sunday, August 3, 2008 12:10 PM ET
The Associated Press
A soldier of the International Security Assistance Force walks past a damaged U.S.-led coalition vehicle near the site of explosion on the outskirts of Kabul, Afghanistan, on Sunday. A roadside bomb hit the vehicle, killing a service member and wounding another, a coalition spokesman said. (Rafiq Maqbool/Associated Press)A roadside bomb struck a military vehicle Sunday on the outskirts the Afghan capital, killing one person and wounding another.
A U.S. military official confirmed the casualties but did not specify their nationalities.
However, a district police chief, Bariyalay Khan, said the vehicle was part of a convoy carrying Americans.
The blast happened on the eastern outskirts of Kabul on a road leading to a police training centre, he said.
Canadian troops in Afghanistan are concentrated in the province of Kandahar in the south.
Najib Rahman, another police official at the scene of the blast, said an American helicopter landed to pick up the wounded while another hovered overhead.
Militants regularly use roadside bombs to attack Afghan and foreign troops in the country, where forces of the former Taliban government are fighting the current regime and its NATO allies.
More than 2,700 people, mostly militants, have been killed so far this year in conflict-related violence, according to an Associated Press tally of figures from Afghan and Western officials

Saturday, August 2, 2008

Play nice Bell! the kids don't like it if mom is cranky


Bell moves to limit internet downloads of competitor ISPs
Last Updated: Thursday, July 31, 2008 4:14 PM ET
By Peter Nowak. CBC News
Bell moved in April to eliminate mandated access to its network by small internet service providers. (Paul Chiasson/Canadian Press)
Bell Canada Inc. is moving to impose download limits on customers of independent internet providers, an act the smaller firms say is designed to eliminate broadband competition and prevent the introduction of new television services.
The Montreal-based company, which cut its own Sympatico customers off from unlimited downloading last year, has proposed extending that plan to firms renting portions of its network in order to provide their own services. That would include a number of smaller wholesale ISP customers such as Chatham, Ont.-based TekSavvy Solutions Inc., Cobourg, Ont.-based Eagle.ca, Mississauga-based Acanac Inc. and Ottawa-based National Capital Freenet.
The limits would range from two gigabytes per month for customers with slower connections of 512 kilobits per second up to 60 GB for those with the faster speeds of five megabits per second, according to Acanac president Paul Louro. Customers who exceed those limits would incur extra charges, much like cellphone subscribers do when they surpass their monthly minutes.
Rocky Gaudreault, president of TekSavvy, said Bell's proposal was unacceptable because it would eliminate the last way in which the smaller wholesale ISPs can differentiate their services.
"This is very much making us little more than a reseller," he said. "We would become mini-Sympaticos."
Louro told CBCNews.ca the repercussions would be even greater because some of the smaller ISPs are getting big enough to start installing their own equipment in Bell's telecommunications offices, which will allow them to offer not only super-fast broadband but also internet-based television. Such a service, known as Internet Protocol Television or IPTV, would require much more capacity than the proposed 60 GB limit and would compete directly with Bell's own ExpressVu satellite television offering.
"It seems like a way to limit our growth so this won't happen," he said. "No ISP at this point can offer IPTV — you're looking at hundreds of gigs, not 60."
Bell officials could not be reached for comment.
The company has taken several steps toward eliminating the smaller ISPs' ability to compete

See the CBC story here

Thursday, July 31, 2008

A Good blog!

The Y Files

Writer and journalist, author of Growing Up in Moscow: Memories of a Soviet Girlhood (1989) and Ceasefire: Why Women and Men Must Join Forces to Achieve True Equality (1999). Columnist for Reason (monthly) and, from 2000 to January 2007, for The Boston Globe (weekly). Born in Moscow, Russia in 1963; came to the United States in 1980. Rutgers University graduate.

Wednesday, July 30, 2008

Elizabeth Hasselbeck should work for RNC or Fox News

Unfortunately, Ms. Hasselbeck has struck again! In today's (Wed. July 30/08) episode of The View, she lamented that Barak Obama gave a copy of his Wailing Wall prayer to the Israeli press so it could be published in its entirety. For those who don't know, Wailing Wall prayers are usually considered confidential, except if you are a politician. I say this because the press in the U.S. is writing about the fashion sense of the entire Obama family, right down to the shade of lipstick worn by Mrs. Obama. If lipstick colour preferences are news, then you can guarantee that Mr. Obama's prayer would have been leaked anyway. Yes Elizabeth, its called controlling the story.

Moving on from this little rant, one of her other annoying habits is the almost pathological belief that anything Senator John McCain does, regardless of how dimwitted, forgetful or obtuse, is either not acknowledged or seen as a minor mistake. Everybody knows she is a Republican, I get that. If anyone asks her what she thinks of his mistakes or his policies, she will dodge the question or become offended. She is as Republican as one can get so if she truly believes that Republican policies are great and engages in political conversations on a nationally televised program, then she may want to read a few briefing books on Republican policies. Her arguments have no substance, just the talking points from either the Republican party or this year, the John McCain campaign. I think she should quit her job at The View and go work for the Republican party or Fox news could add to its supply of talking heads. Perhaps she should join the Bill O'Reilly show but I don't think I'll be that lucky. I can always hope.

Tuesday, July 29, 2008

Cathay Pacific jet damaged in flight lands safely in Vancouver, no injuries

Cathay Pacific jet damaged in flight lands safely in Vancouver, no injuries


---------------------------------------------------------------------------
OK did someone at boeing break a mirror last week?
This is getting nuts!!!!!!!!!!!!!!!!!

Sunday, July 27, 2008

I am NOT A FAN OF Gardasil AT ALL!!!!!!!!!!!!!!!!!!!

SEE LINKS!!!!
http://chealth.canoe.ca/drug_info_details.asp?channel_id=0&relation_id=0&brand_name_id=2456&page_no=2#AdverseEffects -

What side effects are possible with Gardasil?

Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent. The side effects listed below are not experienced by everyone who takes this medication. If you are concerned about side effects, discuss the risks and benefits of this medication with your doctor.

The following side effects have been reported by at least 1% of people taking this medication.

Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.

  • a general feeling of discomfort or illness
  • cough
  • diarrhea
  • dizziness
  • fever
  • joint pain
  • nausea and vomiting
  • pain, swelling, itching, or redness at the injection site
  • stuffy nose
  • toothache
  • trouble sleeping

Check with your doctor as soon as possible if any of the following side effects occur:

  • severe headache
  • signs of an intestinal infection such as sudden and severe vomiting and diarrhea, fever, abdominal cramping, muscle aches, and headache
  • signs of pelvic inflammatory disease such as pain during intercourse, lower abdominal pain, abnormal vaginal discharge which may be foul smelling, fever, irregular menstrual bleeding

Stop taking the medication and seek immediate medical attention if any of the following occur:

  • signs of appendicitis such as swelling and stiffness of the abdomen, pain on the right side of the abdomen when pressed on the left side
  • signs of a severe allergic reaction such as itching, rash, hives, swelling of the face or lips, chest tightness, or shortness of breath

Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking this medication.

Are there any other precautions or warnings for Gardasil?

Before you begin using a medication, be sure to inform your doctor of any medical conditions or allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use this medication.

Bleeding disorders: If you have any bleeding problems (such as hemophilia) or are taking blood thinners such as warfarin (Coumadin®), tell your doctor before receiving this medication.

Health exams: You will still need to have regular health exams after having the vaccine, including Pap tests, HPV DNA tests, or other tests as recommended by your doctor.

Immune system: People with weakened immune systems (e.g., those with cancer, HIV, or taking transplant medications) may not get the full benefits of the vaccine.

Vaccine protection: This vaccine protects only against certain types of HPV and should not be used for treatment of active genital warts or cervical and vaginal cancers. It does not prevent all types of HPV. It does not prevent any other sexually transmitted infections (STIs), such as chlamydia, gonorrhea, or HIV. Condoms should still be used to prevent STIs even after you have received the vaccine.

Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Breast-feeding: It is not known if human papillomavirus vaccine passes into breast milk. If you are a breast-feeding mother and are taking this medication, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.

Children: The safety and effectiveness of this medication have not been established for children less than 9 years of age.

What other drugs could interact with Gardasil?

There may be an interaction between human papillomavirus vaccine and any of the following:

  • medications that weaken the immune system (e.g., certain cancer medications, transplant medications)
  • other vaccines (except for hepatitis B vaccine, which can safely be given at the same time as human papillomavirus vaccine as long as they are injected into different areas of the muscle)

If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:

  • stop taking one of the medications,
  • change one of the medications to another,
  • change how you are taking one or both of the medications, or
  • leave everything as is.

An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.

Medications other than those listed above may interact with this medication. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.

--------------------------------------------------------------------------------------------------------------------------------------

http://www.cbc.ca/news/background/cancer/gardasil.html
http://www.cwhn.ca/resources/cwhn/hpv.html -With a healthy immune system, most people who become infected with HPV can eliminate the virus from their body -- with or without treatment -- within three years (the average is about 9 to 13 months). Most women who get an HPV infection do not develop cervical cancer.

It is important to keep in mind that a compromised immune system, which increases a woman's risk of cervical cancer, can result from many things, including poverty and poor nutrition. Whether in North America or elsewhere in the world, women who die from cervical cancer are often poor. Efforts to eliminate cervical cancer require understanding and addressing this critical fact.

Some pharmaceutical companies and public health agencies are promoting the use of an HPV vaccine by all women, and by all girls beginning at age nine, as a way to eradicate cervical cancer. However, since Gardasil, the only approved vaccine, protects against the two types of HPV that are responsible for 70% of cervical cancers and not against types of the virus responsible for the other 30% of cervical cancers, "reduction" rather than "eradication" is a more accurate goal. Given this fact, proposals to make the vaccine mandatory may not reflect the best use of public health funds at this time.

Pap screening and HPV tests remain important tools in cervical cancer prevention and these tools still do not reach all the girls and women that they should. The HPV vaccine may also prove to be a useful tool, but we do not yet have the full story on its long-term safety, especially in young girls.

Until we know more about long-term safety and duration of effectiveness of the Gardasil HPV vaccine, as well as about how effective it actually is in reducing cervical cancer rates, health care dollars may be better spent in enhancing Pap screening programs (including Pap registries), and reaching the most marginalized populations (poor women, new immigrants, Aboriginal, rural and remote women) with Pap screening.

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

http://en.wikipedia.org/wiki/Gardasil - Canada

A recent opinion article by Abby Lippman PhD, Ryan Melnychuk PhD, Carolyn Shimmin BJ, and Madeline Boscoe RN DU published in the Canadian Medical Association Journal on August 1, 2007 argues that there remain a number of unanswered questions about the HPV vaccine, and that a universal vaccination program in Canada "is premature and could have unintended negative consequences." They also said "we must be certain that spending an estimated $2 billion to vaccinate a population of girls and women in Canada who are already mostly well protected by their own immune systems, safer sex practices and existing screening programs will not perpetuate the existing gaps in care and leave the actual rate of deaths from cervical cancer unchanged." [40]


http://en.wikipedia.org/wiki/Gardasil#Long-Term_Impact -

One unknown property of the vaccines now being researched is their longevity. Since the studies have been of short duration, it is unknown whether the vaccines will last just a few years or for much longer. Further study over time is required to answer this question.

270,000 women died of cervical cancer worldwide in 2002.[25] Acting FDA Administrator Dr. Andrew von Eschenbach said the vaccine will have "a dramatic effect" on the health of women around the world. [9] The American Cancer Society estimated that 9,700 women would develop cervical cancer in the United States in 2006, and 3,700 would die. [26]

Merck and CSL Limited are expected to market Gardasil as a cancer vaccine, rather than an STD vaccine. It remains unclear how widespread the use of the three-shot series will be, in part because of its $360 list price ($120 each for three shots). Merck and CSL have also suggested that governments make vaccination with Gardasil mandatory for school attendance, which has upset some conservative groups. [9] [27] Many such groups also expressed fears that vaccination with Gardasil might give girls a false sense of security regarding sex and increase their level of promiscuity. [28] [9] [29] There is no scientific evidence to prove this claim. Moreover, HPV is not transmitted solely through sexual contact, but may be transmitted via simple hand to hand contact. [30]

Health freedom organizations and other critics of the political power of pharmaceutical companies have vocally denounced the mandatory vaccination scheme as Merck's way of using forced drugging to pay for Vioxx lawsuits. [31]

Another potential issue is that it is not known whether this vaccine has any long-term adverse side effects. Although it has undergone full FDA trials, some fear that detrimental effects may not appear until years or decades after exposure.

See also: vaccine controversy

Both men and women are carriers of HPV. To eradicate the disease, men will eventually need to be vaccinated. Studies are being conducted now to determine the efficacy of vaccinating boys with the current vaccine. [7]

--------------------------------------------------------------------------------------------------------------------------------

http://www.inciid.com/article.php?cat=&id=433 -Gardasil contains 225 mcg of aluminum

For more information go to www.NVIC.org.

-end-

1. Merck & Co., Inc. 2006. Gardasil [Quadrivalent Human Papillomavirus Types 6,11,16,18) Recombinant Vaccine] product insert. Table 6.

2. Food and Drug Administration. May 18, 2006. FDA Background Document for Vaccines and Related Biological Products Advisory Committee: Gardasil HPV Quadrivalent Vaccine.

3. Kawahara M et al. 2001. Effects of aluminum on the neurotoxicty of primary cultured neurons and on the aggregation of betamyloid protein. Brain Res. Bull. 55, 211-217.

4. Redhead K. et al. 1992. Aluminum-adjuvanted vaccines transiently increase aluminum levels in murine brain tissue. Pharmacol. Toxico. 70, 278-280.

5. Sahin G. et al. 1994. Determination of aluminum levels in the kidney, liver and brain of mice treated with aluminum hydroxide. Biol. Trace. Elem. Res. 1194 Apr-May;41 (1-2):129-35.

6. Gherardi M et al. 2001. Macrophagaic myofastitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle. Brain, Vol 124, No. 9, 1821-1831.

7. Shingde M eta la. 2005. Macrophagic myofastitis associated with vaccine derived aluminum. MJA , 183 (03):145-146.

8. Merck & Co. May 18, 2006. Merck briefing document for Vaccines and Related Biological Products Advisory Committee: Gardasil. Table 24.

9. Merck & Co., Inc. 2006. Gardasil product insert: Serious Adverse Experiences.

10. Food and Drug Administration. May 18, 2006. FDA Background Document for Vaccines and Related Biological Products Advisory Committee.: Gardasil. Table 32.

11. Food and Drug Administration. November 29, 2001. Vaccines and Related Biological Products Advisory Committee. Excerpt from transcript.


--------------------------------------------------------------------------------------------------------------------------------------

http://thetyee.ca/News/2007/05/31/HPVVax/ -

Side effects?

In a separate clinical trial (of boys and girls aged nine to 15), Gardasil found that 82 per cent of vaccinated kids had adverse events including the onset of arthritis (compared to 67 per cent with the non-aluminum placebo), but researchers claim they weren't vaccine-related.

"The State [department of health] says Jessica's condition is not connected with the vaccine because the Gardasil website doesn't include it in the list of side effects [from trial participants]," says Vega, who had her daughter vaccinated because her own grandmother died of cervical cancer. "But what else can it be?" she wonders, saying that prior to the inoculation, Jessica had been a healthy, "super-athletic" teen who never even came down with colds. "She's staying really positive and taking this as a challenge," adds Vega who prefers not to comment on whether they'll pursue any legal action.

U.S.-based National Vaccine Information Center (NVIC), an advocacy group that calls itself "a leading critic of one-size-fits-all mass vaccination policies," red flagged the Gardasil vaccine before its FDA approval, stating it had " not proven safe for little girls." They cited Merck's monograph on adverse effects among vaccinated trial participants including two cases of rheumatoid arthritis and five cases of arthritis. They were especially concerned about long term effects among girls receiving both Gardasil and a hepatitis B vaccine.

Since the vaccine's approval, the group says it has tracked adverse events through a reporting system, starting with two 16-year-olds vaccinated within two weeks of FDA-approval who were eventually diagnosed with Guillain-Barré Syndrome.

-------------------------------------------------------------------------------------------------------------------------------------

http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/phase1-decision/drug-med/nd_ad_2006_gardasil_102682_e.html -


Home > Drugs & Health Products > Drug Products > Summary Basis of Decision > Summary Basis of Decision: Phase 1 > Phase 1: Drugs
Contact
Centre for Biologics Evaluation
This document is also available in PDF format
[ nd_ad_2006_gardasil_102682_e.pdf ]
Pages: 2, Size: 17 K, Date: 2006-10-23

Date issued October 23, 2006

NOTICE OF DECISION for GARDASILTM

On July 10, 2006, Health Canada issued a Notice of Compliance to Merck Frosst Canada Ltd. for the vaccine product GardasilTM.

Gardasil is a quadrivalent Human Papillomavirus (HPV) (Types, 6, 11, 16, 18) recombinant vaccine and an active immunizing agent. Gardasil contains as active ingredients, highly purified virus-like particles (VLPs) of the recombinant major capsid (L1) protein of HPV types 6, 11, 16, and 18. As the VLPs do not contain viral DNA, they cannot infect cells or reproduce. Data from pre-clinical studies suggest that the efficacy of L1 VLP vaccines is mediated by the development of humoral immune responses.

Gardasil is indicated in girls and women 9-26 years of age for the prevention of infection caused by the HPV (Types 6, 11, 16, and 18) and the following diseases associated with these HPV types: cervical cancer, vulvar and vaginal cancer, genital warts (condyloma acuminata), cervical adenocarcinoma in situ (AIS), cervical intraepithelial neoplasia (CIN) grades 1, 2 and 3, vulvar intraepithelial neoplasia (VIN) grades 2 and 3, and vaginal intraepithelial neoplasia (VaIN) grades 2 and 3.

Gardasil was reviewed under the Priority Review Policy as it offers a new prevention method of the indicated conditions that is expected to at least complement and augment the prevention of cervical cancer, through the existing screening program in Canada .

The market authorization was based on submitted data from quality control studies and a total of 10 pre-clinical studies and 12 clinical studies. The efficacy of Gardasil was assessed in 4 placebo-controlled, double-blind, randomized Phase II and III clinical studies. Gardasil was efficacious against HPV disease caused by each of the 4 HPV types contained in the vaccine. The efficacy of Gardasil in reducing the incidence of CIN (any grade, including CIN 2/3); AIS; genital warts; VIN (any grade); and VaIN (any grade) was demonstrated in a population consisting of individuals who received all three vaccinations within one year of enrollment, did not have major deviations from the study protocol, and were naïve (negative cervicovaginal specimens and seronegative) to the relevant HPV types (6, 11, 16, and 18) prior to the first dose and one month following the third dose.

Gardasil (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) is presented as a suspension for injection. Gardasil should be administered intramuscularly as three separate 0.5 mL-doses according to the schedule outlined in the dosing guidelines available in the Product Monograph.

Gardasil is contraindicated for patients who are hypersensitive to the active substance or to any of the excipients of the vaccine. For a complete listing, see the Dosage Forms, Composition and Packaging section of the Product Monograph. Individuals who develop symptoms indicative of hypersensitivity after receiving a dose of Gardasil should not receive further doses. Gardasil should be administered under the conditions stated in the Product Monograph taking into consideration the potential risks associated with the administration of this drug product. Detailed conditions for the use of Gardasil are described in the Product Monograph.

Based on the Health Canada review of data on quality, safety, and effectiveness, Health Canada considers that the benefit/risk profile of Gardasil is favourable for the prevention of infection caused by the HPV (Types 6, 11, 16, and 18) and the following diseases associated with these HPV types: cervical cancer, vulvar and vaginal cancer, genital warts (condyloma acuminata), cervical adenocarcinoma in situ (AIS), cervical intraepithelial neoplasia (CIN) grades 1, 2, and 3, vulvar intraepithelial neoplasia (VIN) grades 2 and 3, and vaginal intraepithelial neoplasia (VaIN) grades 2 and 3 in girls and women 9-26 years of age.

Gardasil is a Trademark of Merck & Co., Inc.
Used under license.

Notices of Decision (NDs) are produced in accordance with the Summary Basis of Decision (SBD) initiative. All NDs will be reproduced within the corresponding SBD, normally available within 5 months of product authorization.

--------------------------------------------------------------------------------------------------------------------------------------

http://www.google.ca/search?q=gardasil+side+effects&revid=1230239286&sa=X&oi=revisions_inline&resnum=0&ct=broad-revision&cd=1

--------------------------------------------------------------------------------------------------------------------------------------